VY BlackRock Health Sciences Opportunities Portfolio

Scorecard
2 / 5 Stars
Lipper
---
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
---
TheStreet.com
A+ (Buy)

Fund Fees

Updated 05.01.2014

Maximum Sales Fees %
Initial
Deferred

Updated 05.01.2014

Maximum Fees %
Administrative 0.1
Management 0.75
Redemption

Updated 05.01.2014

Actual Fees %
12b-1
Management 0.75
Net Expense Ratio: Annual Report 0.64
Net Expense Ratio: Prospectus 0.75

Updated 07.03.2014

Total Cost Projections
3-Year $240.00
5-Year $417.00
10-Year $930.00

Purchase Information

Updated 05.01.2014

Minimum Investments
Initial $0.00
Additional
Initial IRA
Additional IRA
Initial AIP
Additional AIP